Rubicon Research Private Limited – Trademark Portfolio

Entity Type: 11

Rubicon Research Private Limited holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 3 trademarks are registered and 4 are pending. Notable registered marks include EZYNIN, RALDESY, and TEMANAZ. The owner is based in Maharashtra.

Wagle Estate, Thane West

MedOne House, B - 75, Road No 33,

Maharashtra 400604 , IN

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RALDESY
RALDESY
Pending 2024
RALDESY
RALDESY
Pending 2024
RALDESY
RALDESY
Registered 2024
AUROTON
AUROTON
Pending 2023
EZYNIN
EZYNIN
Registered 2023
TEMANAZ
TEMANAZ
Registered 2023

Trademark Classifications

Rubicon Research Private Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Rubicon Research Private Limited have?

Rubicon Research Private Limited has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending.

What trademark classes does Rubicon Research Private Limited file in?

Rubicon Research Private Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Rubicon Research Private Limited's most well-known trademarks?

Rubicon Research Private Limited's registered trademark portfolio includes well-known marks such as EZYNIN, RALDESY, and TEMANAZ. These are among 3 currently registered trademarks in the portfolio.

What is Rubicon Research Private Limited's trademark registration success rate?

Rubicon Research Private Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.